Mineralys Therapeutics Is Maintained at Buy by Goldman Sachs

Dow JonesFeb 13 12:26 ET · Ratings

Goldman Sachs Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Cuts Target Price to $24

Moomoo NewsFeb 13 08:31 ET · Ratings

Wells Fargo Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsFeb 13 07:31 ET · Ratings

H.C. Wainwright Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsFeb 13 07:31 ET · Ratings

Analysts' Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Biogen (BIIB) and Mineralys Therapeutics, Inc. (MLYS)

TipRanksFeb 13 07:10 ET · Ratings

Mineralys Therapeutics Analyst Ratings

BenzingaFeb 13 06:44 ET · Ratings